| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH6 MYH8 MYH10 MAP1A MYO5B ENC1 SORBS1 DBN1 LCP1 KLHL20 IQGAP1 MISP XIRP2 COBL MACF1 DMD PLS3 MYBPC1 | 1.22e-07 | 479 | 186 | 19 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | MYH2 MYH6 MYH8 MYH10 MYO5B DBN1 LCP1 IQGAP1 MISP XIRP2 MACF1 PLS3 | 1.53e-06 | 227 | 186 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 MYH6 MYH8 MYH10 MAP1A MYO5B ENC1 NUMA1 SORBS1 FTCD DBN1 LCP1 KLHL20 IQGAP1 MISP XIRP2 PRKAA1 KIF14 COBL MACF1 DMD PLS3 FBXW11 MYBPC1 KPNB1 HSP90AB1 | 1.14e-05 | 1099 | 186 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8B3 MYH8 MYO5B ABCA13 RNF213 RFC1 DDX10 ATP2C2 KIF14 MACF1 MORC3 DNAH9 FIGNL1 RAD17 HSP90AB1 | 1.73e-05 | 441 | 186 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8B3 MYH2 MYH6 MYH8 MYH10 MYO5B ABCA13 RNF213 RFC1 DDX10 ATP2C2 KIF14 MACF1 MORC3 DNAH9 FIGNL1 RAD17 HSP90AB1 | 1.84e-05 | 614 | 186 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.60e-05 | 38 | 186 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.20e-04 | 118 | 186 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ribosome binding | 1.33e-04 | 120 | 186 | 7 | GO:0043022 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.77e-04 | 43 | 186 | 4 | GO:0008307 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT26 MYH6 MYH10 MYOM1 MAP1A MYO5B KRT27 NUMA1 APOA1 SORBS1 DBN1 LCP1 TF IQGAP1 CEP120 XIRP2 WASHC5 ARHGAP12 KIF14 COBL KRT25 PLS3 MYBPC1 KPNB1 HSP90AB1 | 1.17e-06 | 957 | 182 | 25 | GO:0097435 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 7.42e-06 | 15 | 182 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.63e-05 | 18 | 182 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 5.46e-05 | 9 | 182 | 3 | GO:0160063 | |
| GeneOntologyCellularComponent | myosin filament | 7.04e-08 | 25 | 186 | 6 | GO:0032982 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 KRT26 ZWILCH MYH6 MYH8 MYH10 MYOM1 MAP1A KRT27 NUMA1 DBN1 LCP1 TEK TTLL8 RYR3 IQGAP1 MISP XIRP2 KIF14 COBL MACF1 DMD SPAG17 DNAH9 KRT25 PLS3 FBXW11 MYBPC1 | 1.97e-06 | 1179 | 186 | 28 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 KRT26 ZWILCH MYH6 MYH8 MYH10 MYOM1 MAP1A KRT27 NUMA1 DBN1 LCP1 TEK TTLL8 RYR3 IQGAP1 MISP XIRP2 KIF14 COBL MACF1 DMD SPAG17 DNAH9 KRT25 PLS3 FBXW11 MYBPC1 | 2.24e-06 | 1187 | 186 | 28 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | SHLD2 MYH2 MYH6 MYH8 MYH10 MYO5B SORBS1 DBN1 LCP1 TEK KLHL20 IQGAP1 MISP XIRP2 COBL MACF1 ADAM17 PLS3 | 4.18e-06 | 576 | 186 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 5.60e-05 | 9 | 186 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | actomyosin | 8.58e-05 | 117 | 186 | 7 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 9.05e-05 | 118 | 186 | 7 | GO:0032432 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CYBB STRN3 MYH10 RAB17 MAP1A MYO5B ENC1 NUMA1 DBN1 TF CADM2 KLHL20 ITPR3 SNX14 KCNA4 ABHD17B WASHC5 PRKAA1 COBL DMD RAPGEF2 CTSV FBXW11 LGI1 HSP90AB1 | 9.42e-05 | 1228 | 186 | 25 | GO:0036477 |
| GeneOntologyCellularComponent | myosin II complex | 1.05e-04 | 28 | 186 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT26 ZWILCH MAP1A KRT27 NUMA1 DBN1 LCP1 TEK TTLL8 IQGAP1 MISP KIF14 COBL MACF1 DMD SPAG17 DNAH9 KRT25 PLS3 FBXW11 | 1.57e-04 | 899 | 186 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | neuronal cell body | CYBB STRN3 MYH10 RAB17 MAP1A MYO5B ENC1 NUMA1 DBN1 CADM2 ITPR3 WASHC5 PRKAA1 COBL DMD RAPGEF2 CTSV FBXW11 HSP90AB1 | 1.73e-04 | 835 | 186 | 19 | GO:0043025 |
| GeneOntologyCellularComponent | myosin complex | 1.79e-04 | 59 | 186 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.35e-04 | 14 | 186 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | cell body | CYBB PITPNM2 STRN3 MYH10 RAB17 MAP1A MYO5B ENC1 NUMA1 DBN1 CADM2 ITPR3 WASHC5 PRKAA1 COBL DMD RAPGEF2 CTSV FBXW11 HSP90AB1 | 2.41e-04 | 929 | 186 | 20 | GO:0044297 |
| GeneOntologyCellularComponent | actin filament | 3.38e-04 | 146 | 186 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | muscle myosin complex | 3.56e-04 | 16 | 186 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 3.93e-04 | 107 | 186 | 6 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 3.93e-04 | 107 | 186 | 6 | GO:0001725 | |
| GeneOntologyCellularComponent | cell cortex | ZHX3 MYH2 MYH10 MYO5B NUMA1 DBN1 IQGAP1 MISP CSNK1G2 COBL MACF1 | 5.11e-04 | 371 | 186 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 6.05e-04 | 19 | 186 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | dendrite | CYBB STRN3 MYH10 RAB17 MAP1A MYO5B NUMA1 DBN1 TF KLHL20 ITPR3 SNX14 KCNA4 ABHD17B PRKAA1 COBL LGI1 HSP90AB1 | 6.73e-04 | 858 | 186 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CYBB STRN3 MYH10 RAB17 MAP1A MYO5B NUMA1 DBN1 TF KLHL20 ITPR3 SNX14 KCNA4 ABHD17B PRKAA1 COBL LGI1 HSP90AB1 | 6.91e-04 | 860 | 186 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | apical part of cell | SLC6A18 SLC12A6 RAB17 MYO5B NUMA1 TEK TF IQGAP1 ITPR3 PRKAA1 ADAM17 RAPGEF2 CTSV HSP90AB1 | 8.73e-04 | 592 | 186 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.05e-03 | 129 | 186 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | postsynaptic recycling endosome membrane | 1.15e-03 | 6 | 186 | 2 | GO:0098944 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.46e-03 | 93 | 186 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.55e-03 | 26 | 186 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | CYBB GALNT1 MYO5B DBN1 LCP1 TEK TF KLHL20 RYR3 ITPR3 ATP2C2 DEF6 SEC16A COBL DMD RAPGEF2 FIGNL1 HSP90AB1 | 1.75e-03 | 934 | 186 | 18 | GO:0048471 |
| GeneOntologyCellularComponent | condensed chromosome | 1.77e-03 | 307 | 186 | 9 | GO:0000793 | |
| GeneOntologyCellularComponent | sarcomere | 1.79e-03 | 249 | 186 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | blood microparticle | 1.85e-03 | 144 | 186 | 6 | GO:0072562 | |
| GeneOntologyCellularComponent | mitotic spindle astral microtubule | 2.13e-03 | 8 | 186 | 2 | GO:0061673 | |
| GeneOntologyCellularComponent | axon initial segment | 2.14e-03 | 29 | 186 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | myofibril | 3.16e-03 | 273 | 186 | 8 | GO:0030016 | |
| Domain | Myosin-like_IQ_dom | 8.89e-07 | 19 | 183 | 5 | IPR027401 | |
| Domain | - | 8.89e-07 | 19 | 183 | 5 | 4.10.270.10 | |
| Domain | DUF2012 | 3.68e-06 | 4 | 183 | 3 | PF09430 | |
| Domain | DUF2012 | 3.68e-06 | 4 | 183 | 3 | IPR019008 | |
| Domain | Myosin_N | 1.12e-05 | 15 | 183 | 4 | PF02736 | |
| Domain | Myosin_N | 1.12e-05 | 15 | 183 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 2.45e-05 | 18 | 183 | 4 | PF01576 | |
| Domain | Myosin_tail | 2.45e-05 | 18 | 183 | 4 | IPR002928 | |
| Domain | Myosin_head_motor_dom | 3.30e-05 | 38 | 183 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.30e-05 | 38 | 183 | 5 | PS51456 | |
| Domain | Myosin_head | 3.30e-05 | 38 | 183 | 5 | PF00063 | |
| Domain | MYSc | 3.30e-05 | 38 | 183 | 5 | SM00242 | |
| Domain | Carb-bd-like_fold | 5.00e-05 | 8 | 183 | 3 | IPR013784 | |
| Domain | CH | 6.35e-05 | 70 | 183 | 6 | PF00307 | |
| Domain | ACTININ_2 | 6.83e-05 | 23 | 183 | 4 | PS00020 | |
| Domain | ACTININ_1 | 6.83e-05 | 23 | 183 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.83e-05 | 23 | 183 | 4 | IPR001589 | |
| Domain | IQ | 6.88e-05 | 71 | 183 | 6 | PF00612 | |
| Domain | - | 6.88e-05 | 71 | 183 | 6 | 1.10.418.10 | |
| Domain | CH | 8.05e-05 | 73 | 183 | 6 | PS50021 | |
| Domain | CH-domain | 9.37e-05 | 75 | 183 | 6 | IPR001715 | |
| Domain | IQ | 1.44e-04 | 81 | 183 | 6 | SM00015 | |
| Domain | CarboxyPept_regulatory_dom | 2.46e-04 | 13 | 183 | 3 | IPR014766 | |
| Domain | - | 2.46e-04 | 13 | 183 | 3 | 2.60.40.1120 | |
| Domain | P-loop_NTPase | MYH2 MYH6 MYH8 MYH10 RAB17 MYO5B ABCA13 RNF213 RFC1 NLRC4 IQGAP1 DDX10 N4BP2 MTIF2 KIF14 CHST2 DNAH9 FIGNL1 GNL3 RAD17 | 2.54e-04 | 848 | 183 | 20 | IPR027417 |
| Domain | IQ_motif_EF-hand-BS | 2.57e-04 | 90 | 183 | 6 | IPR000048 | |
| Domain | IQ | 3.07e-04 | 93 | 183 | 6 | PS50096 | |
| Domain | CH | 4.39e-04 | 65 | 183 | 5 | SM00033 | |
| Domain | CarboxyPept-like_regulatory | 5.69e-04 | 17 | 183 | 3 | IPR008969 | |
| Domain | HATPase_c | 7.99e-04 | 19 | 183 | 3 | PF02518 | |
| Domain | - | 9.33e-04 | 20 | 183 | 3 | 3.30.565.10 | |
| Domain | Myosin_S1_N | 9.36e-04 | 5 | 183 | 2 | IPR008989 | |
| Domain | HATPase_C | 1.08e-03 | 21 | 183 | 3 | IPR003594 | |
| Domain | WW | 1.14e-03 | 47 | 183 | 4 | PF00397 | |
| Domain | WW | 1.24e-03 | 48 | 183 | 4 | SM00456 | |
| Domain | RIH_assoc-dom | 1.40e-03 | 6 | 183 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.40e-03 | 6 | 183 | 2 | PF08709 | |
| Domain | PEROXIDASE_1 | 1.40e-03 | 6 | 183 | 2 | PS00435 | |
| Domain | RIH_assoc | 1.40e-03 | 6 | 183 | 2 | PF08454 | |
| Domain | RIH_dom | 1.40e-03 | 6 | 183 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.40e-03 | 6 | 183 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.40e-03 | 6 | 183 | 2 | IPR015925 | |
| Domain | - | 1.40e-03 | 6 | 183 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.40e-03 | 6 | 183 | 2 | PF01365 | |
| Domain | WW_DOMAIN_1 | 1.56e-03 | 51 | 183 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 1.56e-03 | 51 | 183 | 4 | PS50020 | |
| Domain | WW_dom | 1.67e-03 | 52 | 183 | 4 | IPR001202 | |
| Domain | zf-CW | 1.94e-03 | 7 | 183 | 2 | PF07496 | |
| Domain | ZF_CW | 1.94e-03 | 7 | 183 | 2 | PS51050 | |
| Domain | Znf_CW | 1.94e-03 | 7 | 183 | 2 | IPR011124 | |
| Domain | THIOL_PROTEASE_CYS | 2.04e-03 | 26 | 183 | 3 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 2.28e-03 | 27 | 183 | 3 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 2.28e-03 | 27 | 183 | 3 | PS00639 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.57e-03 | 8 | 183 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 2.57e-03 | 8 | 183 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 2.57e-03 | 8 | 183 | 2 | IPR019742 | |
| Domain | A2M_N_2 | 2.57e-03 | 8 | 183 | 2 | SM01359 | |
| Domain | - | 2.57e-03 | 8 | 183 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 2.57e-03 | 8 | 183 | 2 | SM01361 | |
| Domain | A2M | 2.57e-03 | 8 | 183 | 2 | SM01360 | |
| Domain | AAA | 2.98e-03 | 144 | 183 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 2.98e-03 | 144 | 183 | 6 | IPR003593 | |
| Domain | MIR | 4.08e-03 | 10 | 183 | 2 | PF02815 | |
| Domain | HMG_BOX_1 | 4.08e-03 | 10 | 183 | 2 | PS00353 | |
| Domain | IPPc | 4.08e-03 | 10 | 183 | 2 | IPR000300 | |
| Domain | An_peroxidase | 4.08e-03 | 10 | 183 | 2 | PF03098 | |
| Domain | A2M | 4.08e-03 | 10 | 183 | 2 | PF00207 | |
| Domain | MIR_motif | 4.08e-03 | 10 | 183 | 2 | IPR016093 | |
| Domain | A2M_N_2 | 4.08e-03 | 10 | 183 | 2 | IPR011625 | |
| Domain | A2M_comp | 4.08e-03 | 10 | 183 | 2 | IPR011626 | |
| Domain | Haem_peroxidase_animal | 4.08e-03 | 10 | 183 | 2 | IPR019791 | |
| Domain | A2M_recep | 4.08e-03 | 10 | 183 | 2 | PF07677 | |
| Domain | A2M_comp | 4.08e-03 | 10 | 183 | 2 | PF07678 | |
| Domain | IPPc | 4.08e-03 | 10 | 183 | 2 | SM00128 | |
| Domain | A2M_N | 4.08e-03 | 10 | 183 | 2 | PF01835 | |
| Domain | MIR | 4.08e-03 | 10 | 183 | 2 | PS50919 | |
| Domain | MIR | 4.08e-03 | 10 | 183 | 2 | SM00472 | |
| Domain | A2M_N | 4.08e-03 | 10 | 183 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 4.08e-03 | 10 | 183 | 2 | IPR009048 | |
| Domain | Haem_peroxidase | 4.08e-03 | 10 | 183 | 2 | IPR010255 | |
| Domain | ALPHA_2_MACROGLOBULIN | 4.08e-03 | 10 | 183 | 2 | PS00477 | |
| Domain | PEROXIDASE_3 | 4.08e-03 | 10 | 183 | 2 | PS50292 | |
| Domain | A2M_N_2 | 4.08e-03 | 10 | 183 | 2 | PF07703 | |
| Domain | - | 4.08e-03 | 10 | 183 | 2 | 1.10.640.10 | |
| Domain | Macroglobln_a2 | 4.08e-03 | 10 | 183 | 2 | IPR001599 | |
| Domain | HEAT_REPEAT | 4.94e-03 | 70 | 183 | 4 | PS50077 | |
| Domain | PTBI | 4.95e-03 | 11 | 183 | 2 | SM00310 | |
| Domain | IRS_PTB | 5.91e-03 | 12 | 183 | 2 | PS51064 | |
| Domain | - | 5.91e-03 | 12 | 183 | 2 | 1.50.10.20 | |
| Domain | Acyl-CoA_dh_1 | 6.94e-03 | 13 | 183 | 2 | PF00441 | |
| Domain | Calpain_III | 6.94e-03 | 13 | 183 | 2 | PF01067 | |
| Domain | Calpain_domain_III | 6.94e-03 | 13 | 183 | 2 | IPR022682 | |
| Domain | IRS | 8.04e-03 | 14 | 183 | 2 | PF02174 | |
| Domain | IRS_PTB | 8.04e-03 | 14 | 183 | 2 | IPR002404 | |
| Domain | Calpain_cysteine_protease | 8.04e-03 | 14 | 183 | 2 | IPR022684 | |
| Domain | Keratin_I | 9.13e-03 | 44 | 183 | 3 | IPR002957 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 9.22e-03 | 15 | 183 | 2 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 9.22e-03 | 15 | 183 | 2 | IPR009100 | |
| Domain | Peptidase_C2 | 9.22e-03 | 15 | 183 | 2 | PF00648 | |
| Domain | CysPc | 9.22e-03 | 15 | 183 | 2 | SM00230 | |
| Pubmed | MYH10 IRS4 NUMA1 KRI1 LARP1 RFC1 KRR1 LCP1 IQGAP1 ITPR3 DDX10 GTF2I UTP15 BAZ2A MCM3AP SEC16A KIF14 PYGB MACF1 NUP93 GCN1 NUP160 GNL3 KPNB1 | 2.57e-13 | 653 | 191 | 24 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MRPS31 MYH10 IRS4 COX4I1 AZGP1 NUMA1 KRI1 LARP1 DBN1 RFC1 RRBP1 KRR1 OGDH IQGAP1 NOMO1 DDX10 LIG3 TRMT10C GTF2I UTP15 SUPT16H MTR KIF14 SMARCE1 SCPEP1 NUP93 CHST2 GCN1 PLS3 NUP160 GNL3 MYBPC1 KPNB1 HSP90AB1 | 4.84e-13 | 1425 | 191 | 34 | 30948266 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | STRN3 MYH10 KIAA0232 KRI1 SORBS1 OCRL LCP1 IQGAP1 ESYT2 CEP120 NOMO2 WASHC5 N4BP2 CAPN7 ARHGAP12 KIF14 COBL NUP93 MORC3 MGA PLS3 GNL3 KPNB1 HSP90AB1 | 6.79e-11 | 853 | 191 | 24 | 28718761 |
| Pubmed | MYH10 IRS4 MYO5B COX4I1 DUSP8 KRI1 RNF213 ITPR3 ESYT2 HSPA12A TRMT10C PTPRD WASHC5 SUPT16H SEC16A INTS4 KIF14 ELP2 NUP93 DMD FTO GCN1 TOP3B FBXW11 KPNB1 HSP90AB1 | 1.60e-10 | 1049 | 191 | 26 | 27880917 | |
| Pubmed | IRS4 NUMA1 RFC1 IQGAP1 ESYT2 TRMT10C GTF2I CEP120 NOMO2 PRKAA1 TMX4 INTS4 PYGB ELP2 NUP93 NUP160 FBXW11 KPNB1 HSP90AB1 | 3.46e-10 | 560 | 191 | 19 | 35241646 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZHX3 STRN3 MYH10 IRS4 MAP1A RBM10 NUMA1 LARP1 OCRL DBN1 RFC1 RRBP1 DDX10 LIG3 GTF2I BAZ2A SEC16A MACF1 SMARCE1 IRS2 GCN1 GNL3 KPNB1 HSP90AB1 | 4.21e-10 | 934 | 191 | 24 | 33916271 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | KRI1 APOA1 SIX1 LCP1 TF NOMO1 ITPR3 ESYT2 TRMT10C GTF2I PTPRD ACAD11 PRKAA1 SEC16A C3 IRS2 TTC13 NUP93 DMD GCN1 PLS3 NUP160 FBXW11 KPNB1 | 9.66e-10 | 974 | 191 | 24 | 28675297 |
| Pubmed | PITPNM2 SLC12A6 STRN3 MYH6 MYH10 MAP1A MYO5B COX4I1 LARP1 SORBS1 DBN1 RRBP1 OGDH TF CADM2 IQGAP1 MISP HSPA12A WASHC5 PRKAA1 SEC16A PYGB MACF1 DMD RAPGEF2 PLS3 LGI1 KPNB1 HSP90AB1 | 1.36e-09 | 1431 | 191 | 29 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MRPS31 MYH10 MYO5B AZGP1 NUMA1 KRI1 LARP1 DBN1 RFC1 RRBP1 KRR1 DNAJC2 IQGAP1 ITPR3 MISP TRMT10C GTF2I UTP15 SUPT16H KIF14 C3 NUP93 PLS3 NUP160 GNL3 KPNB1 HSP90AB1 | 1.56e-09 | 1257 | 191 | 27 | 36526897 |
| Pubmed | MRPS31 MYH2 MYH10 IRS4 COX4I1 NUMA1 KRI1 LARP1 RNF213 HMGCR RFC1 KRR1 OGDH IQGAP1 ITPR3 LIG3 ESYT2 TRMT10C GTF2I COG1 SUPT16H KIF14 COBL NUP93 GCN1 FIGNL1 PLS3 FBXW11 KPNB1 | 1.57e-09 | 1440 | 191 | 29 | 30833792 | |
| Pubmed | MRPS31 SLC12A6 MYH2 STRN3 MYH6 MYH8 MYH10 IRS4 MYO5B NUMA1 LARP1 DBN1 RRBP1 LCP1 OGDH IQGAP1 KIAA0825 COG1 N4BP2 ARHGAP12 SUPT16H MACF1 ZNF84 DMD SPAG17 TOP3B MYBPC1 KPNB1 HSP90AB1 | 1.62e-09 | 1442 | 191 | 29 | 35575683 | |
| Pubmed | MYH10 AZGP1 DBN1 RRBP1 LCP1 IQGAP1 ESYT2 MISP GTF2I SUPT16H AHSG MACF1 DMD GCN1 PLS3 KPNB1 HSP90AB1 | 2.07e-09 | 488 | 191 | 17 | 31324722 | |
| Pubmed | MYH10 IRS4 RBM10 AZGP1 NUMA1 KRI1 LARP1 OCRL DBN1 DNAJC2 TRMT10C GTF2I SUPT16H AHSG NUP93 MMAB GCN1 NUP160 GNL3 | 3.19e-09 | 641 | 191 | 19 | 36057605 | |
| Pubmed | MRPS31 COX4I1 KRI1 RRBP1 OGDH DNAJC2 NOMO1 ITPR3 DDX10 ESYT2 HSPA12A TRMT10C DNAJC28 UTP15 BAZ2A NOMO2 N4BP2 MTIF2 SUPT16H TMX4 MTR MACF1 ELP2 TTC13 MMAB TOP3B PLS3 GNL3 VPS13B | 3.23e-09 | 1487 | 191 | 29 | 33957083 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZHX3 IRS4 COX4I1 RBM10 NUMA1 KRI1 LARP1 DBN1 RFC1 RRBP1 KRR1 JMJD1C DDX10 LIG3 GTF2I BAZ2A SUPT16H SEC16A SMARCE1 MGA GNL3 KPNB1 HSP90AB1 | 3.35e-09 | 954 | 191 | 23 | 36373674 |
| Pubmed | MYH10 IRS4 RBM10 KRI1 LARP1 DBN1 RRBP1 DDX10 GTF2I SEC16A COBL KPNB1 HSP90AB1 | 4.64e-09 | 274 | 191 | 13 | 34244482 | |
| Pubmed | MRPS31 MYH10 IRS4 KRI1 LARP1 RFC1 RRBP1 OGDH IQGAP1 SORCS1 ESYT2 TRMT10C GTF2I BAZ2A DMD GCN1 PLS3 GNL3 FBXW11 KPNB1 HSP90AB1 | 4.72e-09 | 809 | 191 | 21 | 32129710 | |
| Pubmed | NUMA1 KRI1 LARP1 RNF213 KRR1 DDX10 UTP15 BAZ2A MCM3AP SUPT16H NUP93 NUP160 GNL3 FBXW11 | 5.27e-09 | 332 | 191 | 14 | 25693804 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | STRN3 ZWILCH AZGP1 NUMA1 LARP1 APOA1 RRBP1 TF GMNN IQGAP1 MISP GTF2I CEP120 WASHC5 AHSG KIF14 SMARCE1 NUP93 MORC3 GCN1 PLS3 NUP160 GNL3 VPS13B KPNB1 | 5.74e-09 | 1155 | 191 | 25 | 20360068 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 AZGP1 NUMA1 OCRL RFC1 RRBP1 KRR1 IQGAP1 DDX10 LIG3 GTF2I UTP15 BAZ2A WASHC5 MCM3AP A2ML1 SUPT16H SEC16A PYGB MACF1 NUP93 MGA GCN1 NUP160 GNL3 KPNB1 HSP90AB1 | 7.41e-09 | 1353 | 191 | 27 | 29467282 |
| Pubmed | NUMA1 KRI1 DBN1 RFC1 OGDH GTF2I SUPT16H MACF1 DMD GNL3 VPS13B HSP90AB1 | 7.78e-09 | 234 | 191 | 12 | 36243803 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRPS31 STRN3 MYH10 IRS4 COX4I1 RNF213 OCRL RRBP1 OGDH ITPR3 ESYT2 TRMT10C DNAJC28 UTP15 BAZ2A MTIF2 ARHGAP12 SUPT16H TMX4 SEC16A MTR TTC13 MMAB FIGNL1 TOP3B NUP160 GNL3 VPS13B | 1.50e-08 | 1496 | 191 | 28 | 32877691 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MRPS31 MYH10 NUMA1 KRI1 LARP1 RFC1 RRBP1 KRR1 LCP1 TF DDX10 ESYT2 TRMT10C GTF2I UTP15 BAZ2A WASHC5 SUPT16H SEC16A NUP93 MORC3 GCN1 NUP160 GNL3 KPNB1 HSP90AB1 | 1.83e-08 | 1318 | 191 | 26 | 30463901 |
| Pubmed | ABCA13 COX4I1 AZGP1 NUMA1 APOA1 KRR1 TF ITPR3 MISP GTF2I SUPT16H AHSG C3 NUP93 PLS3 GNL3 KPNB1 HSP90AB1 | 2.50e-08 | 652 | 191 | 18 | 31180492 | |
| Pubmed | 3.30e-08 | 167 | 191 | 10 | 35833506 | ||
| Pubmed | MYO5B RBM10 AZGP1 DBN1 IQGAP1 MISP GTF2I DEF6 SMARCE1 MGA GCN1 HSP90AB1 | 4.11e-08 | 272 | 191 | 12 | 31010829 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | MRPS31 COX4I1 RBM10 NUMA1 LARP1 RRBP1 LCP1 OGDH TF IQGAP1 TRMT10C SUPT16H PYGB C3 NUP93 GCN1 NUP160 | 5.07e-08 | 607 | 191 | 17 | 39147351 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IRS4 MYO5B RBM10 NUMA1 RRBP1 IQGAP1 ITPR3 DDX10 LIG3 PRKAA1 SUPT16H SEC16A KIF14 MACF1 NUP93 MMAB MGA GCN1 NUP160 GNL3 KPNB1 HSP90AB1 | 5.77e-08 | 1024 | 191 | 22 | 24711643 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | MYH10 RBM10 NUMA1 KRI1 RFC1 JMJD1C DDX10 LIG3 GTF2I BAZ2A SUPT16H MGA | 6.34e-08 | 283 | 191 | 12 | 30585729 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | NUMA1 KRI1 LARP1 KRR1 DDX10 LIG3 GTF2I UTP15 BAZ2A SUPT16H MGA PLS3 GNL3 | 8.03e-08 | 349 | 191 | 13 | 25665578 |
| Pubmed | MRPS31 DPF1 ZHX3 MYH10 IRS4 COX4I1 RBM10 NUMA1 KRI1 LARP1 DBN1 RFC1 KRR1 JMJD1C HMG20B DNTTIP1 DDX10 LIG3 GTF2I SEC16A MTR SMARCE1 NUP93 MGA KAT14 GNL3 | 9.04e-08 | 1429 | 191 | 26 | 35140242 | |
| Pubmed | 1.16e-07 | 22 | 191 | 5 | 24301466 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 1.56e-07 | 197 | 191 | 10 | 29872149 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 36011023 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 16874310 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.63e-07 | 3 | 191 | 3 | 25576386 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH10 NUMA1 LARP1 RRBP1 IQGAP1 ITPR3 SUPT16H SEC16A GCN1 TOP3B | 1.97e-07 | 202 | 191 | 10 | 33005030 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NUMA1 KRI1 LARP1 RFC1 RRBP1 KRR1 OGDH IQGAP1 DDX10 LIG3 ACAD11 UTP15 SUPT16H MACF1 ZC3H7B GCN1 TOP3B GNL3 | 2.40e-07 | 759 | 191 | 18 | 35915203 |
| Pubmed | MRPS31 MYH10 RBM10 NUMA1 LARP1 RNF213 RFC1 TRMT10C PRKAA1 SUPT16H SEC16A MACF1 C3 NUP93 GCN1 GNL3 | 2.52e-07 | 601 | 191 | 16 | 33658012 | |
| Pubmed | DPF1 MAP1A RNF213 TF HMG20B ACAD11 PRPF40B BAZ2A MTIF2 MCM3AP SUPT16H SEC16A MTR MACF1 SMARCE1 ADAM17 IRS2 RAPGEF2 MGA IQCM KAT14 GNL3 | 2.52e-07 | 1116 | 191 | 22 | 31753913 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | MYH10 RBM10 AZGP1 NUMA1 KRI1 LARP1 RFC1 KRR1 IQGAP1 DDX10 LIG3 GTF2I SUPT16H SMARCE1 GNL3 HSP90AB1 | 2.75e-07 | 605 | 191 | 16 | 28977666 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MRPS31 MYH10 COX4I1 NUMA1 KRI1 LARP1 RFC1 RRBP1 KRR1 DNAJC2 IQGAP1 TRMT10C GTF2I PRKAA1 SUPT16H SEC16A MACF1 SMARCE1 IRS2 GCN1 CTSV PLS3 GNL3 KPNB1 HSP90AB1 | 2.83e-07 | 1415 | 191 | 25 | 28515276 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 NUMA1 RFC1 JMJD1C DNTTIP1 DDX10 LIG3 GTF2I BAZ2A SUPT16H SMARCE1 MORC3 SNAPC4 MGA GNL3 KDM4B | 2.94e-07 | 608 | 191 | 16 | 36089195 |
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 3.30e-07 | 50 | 191 | 6 | 27597886 | |
| Pubmed | MYH6 MYH8 MYOM1 COX4I1 APOA1 RRBP1 OGDH DNAJC28 PYGB PLS3 VPS13B HSP90AB1 | 3.42e-07 | 331 | 191 | 12 | 29199018 | |
| Pubmed | MRPS31 IRS4 COX4I1 NUMA1 LARP1 DBN1 RRBP1 IQGAP1 TRMT10C SUPT16H SEC16A AHSG SMARCE1 ELP2 NUP93 PLS3 GNL3 KPNB1 | 3.98e-07 | 786 | 191 | 18 | 29128334 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MRPS31 STRN3 MYH10 IRS4 RBM10 LARP1 DBN1 RFC1 LCP1 IQGAP1 LIG3 GTF2I SUPT16H SEC16A MACF1 SCPEP1 NUP93 GCN1 PLS3 GNL3 KPNB1 HSP90AB1 | 4.12e-07 | 1149 | 191 | 22 | 35446349 |
| Pubmed | IRS4 RBM10 NUMA1 LARP1 DBN1 JMJD1C GTF2I BAZ2A SEC16A KIF14 SMARCE1 MGA GCN1 PLS3 KPNB1 | 4.37e-07 | 549 | 191 | 15 | 38280479 | |
| Pubmed | MYH10 IRS4 RBM10 LARP1 DBN1 RRBP1 KRR1 GTF2I ACAD11 N4BP2 SEC16A MGA PLS3 GNL3 HSP90AB1 | 4.57e-07 | 551 | 191 | 15 | 34728620 | |
| Pubmed | ZHX3 MYH10 RBM10 KIAA0232 SORBS1 VAT1L BAZ2A BTBD7 MCM3AP SEC16A COBL MACF1 VPS13B | 4.64e-07 | 407 | 191 | 13 | 12693553 | |
| Pubmed | MYH10 COX4I1 VAT1L DBN1 OGDH TF CADM2 NOMO1 HSPA12A NOMO2 PYGB DMD NOMO3 KPNB1 HSP90AB1 | 4.68e-07 | 552 | 191 | 15 | 36293380 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MYH10 DBN1 LCP1 OGDH IQGAP1 NOMO1 NOMO2 SUPT16H C3 GCN1 NOMO3 KPNB1 | 5.15e-07 | 344 | 191 | 12 | 30333137 |
| Pubmed | IRS4 KRI1 RFC1 RRBP1 KRR1 LCP1 TF DDX10 GTF2I UTP15 SUPT16H C3 GNL3 KPNB1 | 5.33e-07 | 483 | 191 | 14 | 36912080 | |
| Pubmed | GALNT1 COX4I1 LARP1 RNF213 KRR1 ACOX3 NOMO1 ITPR3 ESYT2 GTF2I ABHD17B CSNK1G2 DEF6 KIF14 PYGB ADAM17 NUP93 MCTP2 GCN1 GNL3 KPNB1 HSP90AB1 | 5.42e-07 | 1168 | 191 | 22 | 19946888 | |
| Pubmed | MYH10 RAB17 NUMA1 KRI1 LARP1 APOA1 RFC1 RRBP1 KRR1 IQGAP1 DNTTIP1 DDX10 TRMT10C GTF2I ACAD11 MCM3AP SUPT16H SEC16A SMARCE1 NUP93 GCN1 PLS3 GNL3 HSP90AB1 | 5.90e-07 | 1371 | 191 | 24 | 36244648 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 6.50e-07 | 4 | 191 | 3 | 31833031 | |
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 9267806 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | MAP1A AZGP1 APOA1 KRR1 LCP1 TF IQGAP1 LIG3 ESYT2 UTP15 A2ML1 AHSG KIF14 C3 GCN1 PLS3 GNL3 | 7.01e-07 | 732 | 191 | 17 | 34732716 |
| Pubmed | SLC12A6 MYH8 MYOM1 SORBS1 JMJD1C XIRP2 SUPT16H INTS4 MACF1 MGA GNL3 MYBPC1 KPNB1 HSP90AB1 | 7.47e-07 | 497 | 191 | 14 | 23414517 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ZHX3 NUMA1 SORBS1 RRBP1 LCP1 RYR3 SNX14 KIAA0825 XIRP2 CAPN7 COBL IRS2 TOP3B KDM4B | 7.47e-07 | 497 | 191 | 14 | 36774506 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MRPS31 MYH2 STRN3 MYH10 AZGP1 KRI1 KRR1 OGDH KLHL20 IQGAP1 DDX10 TRMT10C GTF2I POLR3E SUPT16H NUP93 GCN1 NUP160 FBXW11 RAD17 | 7.94e-07 | 1005 | 191 | 20 | 19615732 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RBM10 NUMA1 DCLRE1B RFC1 RRBP1 JMJD1C HMG20B DNTTIP1 ITPR3 LIG3 ESYT2 MISP GTF2I POLR3E BAZ2A SUPT16H INTS4 SMARCE1 NUP93 MGA KAT14 GNL3 KPNB1 | 7.97e-07 | 1294 | 191 | 23 | 30804502 |
| Pubmed | MYH10 NUMA1 LARP1 RRBP1 OGDH IQGAP1 ITPR3 LIG3 DEF6 SEC16A MACF1 NUP93 | 8.31e-07 | 360 | 191 | 12 | 33111431 | |
| Pubmed | MYH10 RBM10 NUMA1 DBN1 OGDH IQGAP1 ITPR3 LIG3 MISP UTP15 SUPT16H KIF14 MACF1 NUP93 PLS3 NUP160 | 8.65e-07 | 660 | 191 | 16 | 32780723 | |
| Pubmed | ZHX3 MYH10 IRS4 NUMA1 SORBS1 DBN1 LCP1 DDX10 GTF2I WASHC5 SMARCE1 KAT14 PLS3 KPNB1 | 9.24e-07 | 506 | 191 | 14 | 30890647 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | IRS4 MYO5B RBM10 LARP1 RFC1 SIX1 LIG3 GTF2I POLR3E BAZ2A SUPT16H MGA NUP160 KPNB1 HSP90AB1 | 9.25e-07 | 583 | 191 | 15 | 29844126 |
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 1.07e-06 | 243 | 191 | 10 | 36964488 | |
| Pubmed | 1.23e-06 | 191 | 191 | 9 | 33762435 | ||
| Pubmed | MRPS31 IRS4 MAP1A AZGP1 LARP1 RFC1 RRBP1 KRR1 PANX3 IQGAP1 TRMT10C GTF2I BTBD7 SUPT16H SEC16A SMARCE1 NUP93 FTO PLS3 NUP160 GNL3 KPNB1 HSP90AB1 | 1.35e-06 | 1335 | 191 | 23 | 29229926 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 AZGP1 NUMA1 LARP1 DBN1 RRBP1 IQGAP1 ITPR3 DDX10 MISP GTF2I UTP15 SUPT16H C3 NUP93 MCTP2 GNL3 KPNB1 HSP90AB1 | 1.39e-06 | 949 | 191 | 19 | 36574265 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 STRN3 RBM10 NUMA1 LARP1 DBN1 RFC1 RRBP1 IQGAP1 ESYT2 GTF2I BAZ2A SEC16A IRS2 SNAPC4 KDM4B HSP90AB1 | 1.50e-06 | 774 | 191 | 17 | 15302935 |
| Pubmed | MRPS31 MYH10 IRS4 RBM10 LARP1 TRMT10C INTS4 NUP93 GCN1 GNL3 KPNB1 HSP90AB1 | 1.58e-06 | 383 | 191 | 12 | 29331416 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ANKRD35 GALNT1 ARSK COX4I1 RNF213 RRBP1 OGDH IQGAP1 NOMO1 ESYT2 NOMO2 MTIF2 PRKAA1 SUPT16H TMX4 SEC16A SMARCE1 SCPEP1 OXSM ADAM17 MMAB NOMO3 KPNB1 HSP90AB1 | 1.59e-06 | 1451 | 191 | 24 | 30550785 |
| Pubmed | 2.20e-06 | 327 | 191 | 11 | 31409639 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | IRS4 NUMA1 KRI1 KRR1 DDX10 UTP15 BAZ2A SUPT16H KIF14 GNL3 KPNB1 | 2.41e-06 | 330 | 191 | 11 | 33301849 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PITPNM2 SLC12A6 PHYKPL MYH10 RAB17 KIAA0232 ENC1 LARP1 RNF213 RRBP1 OGDH JMJD1C DNTTIP1 ESYT2 GTF2I COBL MACF1 ZNF84 RAPGEF2 MCTP2 GNL3 VPS13B KDM4B FBXW11 | 2.48e-06 | 1489 | 191 | 24 | 28611215 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MRPS31 MYH10 RBM10 AZGP1 NUMA1 KRI1 RFC1 KRR1 JMJD1C IQGAP1 DNTTIP1 DDX10 TRMT10C GTF2I UTP15 SUPT16H GNL3 KPNB1 HSP90AB1 | 2.54e-06 | 989 | 191 | 19 | 36424410 |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 2.59e-06 | 156 | 191 | 8 | 30409884 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 2.79e-06 | 211 | 191 | 9 | 24097068 | |
| Pubmed | 3.03e-06 | 41 | 191 | 5 | 16740002 | ||
| Pubmed | STRN3 MYH10 IRS4 NUMA1 DBN1 RRBP1 LCP1 DNAJC2 IQGAP1 INTS4 PLS3 HSP90AB1 | 3.27e-06 | 411 | 191 | 12 | 36652389 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ZHX3 MYH10 RBM10 RNF213 JMJD1C DDX10 LIG3 MISP BAZ2A MCM3AP SUPT16H | 3.29e-06 | 341 | 191 | 11 | 32971831 |
| Pubmed | MYH10 MAP1A KIAA0232 SORBS1 N4BP2 MCM3AP COBL MACF1 DMD RAPGEF2 MGA GCN1 HSP90AB1 | 3.30e-06 | 486 | 191 | 13 | 20936779 | |
| Pubmed | IRS4 INPP5B NUMA1 LARP1 OCRL DBN1 RRBP1 ITPR3 ESYT2 SEC16A GCN1 VPS13B KPNB1 HSP90AB1 | 3.54e-06 | 568 | 191 | 14 | 37774976 | |
| Pubmed | 3.80e-06 | 116 | 191 | 7 | 21282530 | ||
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 4.50e-06 | 119 | 191 | 7 | 35776542 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.76e-06 | 120 | 191 | 7 | 31413325 | |
| Pubmed | MRPS31 PITPNM2 STRN3 MYH10 MAP1A COX4I1 SORBS1 DBN1 RRBP1 OGDH ESYT2 HSPA12A TRMT10C KCNA4 WASHC5 TMX4 PYGB MACF1 GCN1 HSP90AB1 | 5.24e-06 | 1139 | 191 | 20 | 36417873 | |
| Pubmed | 5.61e-06 | 7 | 191 | 3 | 16819597 | ||
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 6.03e-06 | 47 | 191 | 5 | 14760718 | |
| Pubmed | STRN3 MYH10 NUMA1 SORBS1 DBN1 IQGAP1 KCNA4 PTPRD N4BP2 SUPT16H SEC16A MACF1 RAPGEF2 MGA TOP3B LGI1 KPNB1 HSP90AB1 | 6.87e-06 | 963 | 191 | 18 | 28671696 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MYH10 AZGP1 RNF213 RFC1 OGDH IQGAP1 ESYT2 MISP TRMT10C UTP15 WASHC5 A2ML1 PRKAA1 SUPT16H SEC16A PYGB SMARCE1 NUP93 GCN1 NUP160 KPNB1 HSP90AB1 | 6.90e-06 | 1367 | 191 | 22 | 32687490 |
| Pubmed | STRN3 IRS4 KRI1 LARP1 SORBS1 DBN1 ACAD11 SEC16A KIF14 IRS2 RAPGEF2 NUP160 | 7.48e-06 | 446 | 191 | 12 | 24255178 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | KRT26 MYH10 KRT27 AZGP1 APOA1 LCP1 TF IQGAP1 ORM1 PTPRD CAPN7 AHSG PYGB C3 SCPEP1 FIGNL1 KRT25 KPNB1 HSP90AB1 | 7.80e-06 | 1070 | 191 | 19 | 23533145 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 8.95e-06 | 8 | 191 | 3 | 15257293 | |
| Pubmed | ENC1 SORBS1 FTCD RRBP1 TF RYR3 IQGAP1 PTPRD COG1 NOMO2 MTIF2 ATRNL1 MACF1 SMARCE1 ZNF84 MORC3 RAPGEF2 FBXW11 LGI1 KPNB1 HSP90AB1 | 8.99e-06 | 1285 | 191 | 21 | 35914814 | |
| Pubmed | NUMA1 LARP1 OCRL RRBP1 JMJD1C IQGAP1 ESYT2 ARHGAP12 SEC16A MACF1 IRS2 GCN1 PLS3 KPNB1 HSP90AB1 | 9.70e-06 | 708 | 191 | 15 | 39231216 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | MYH10 IRS4 NUMA1 KRI1 DBN1 JMJD1C DNAJC2 GTF2I SUPT16H NUP93 NUP160 GNL3 FBXW11 HSP90AB1 | 1.02e-05 | 624 | 191 | 14 | 33729478 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MYH2 MYH10 NUMA1 LARP1 DBN1 RFC1 RRBP1 ITPR3 LIG3 GTF2I SUPT16H SEC16A KPNB1 HSP90AB1 | 1.06e-05 | 626 | 191 | 14 | 33644029 |
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 1.06e-05 | 189 | 191 | 8 | 29449217 | |
| Interaction | SOX2 interactions | MRPS31 DPF1 MAP1A AZGP1 NUMA1 KRI1 LARP1 APOA1 DBN1 RFC1 KRR1 SIX1 LCP1 TF JMJD1C IQGAP1 DNTTIP1 LIG3 ESYT2 GTF2I UTP15 A2ML1 SUPT16H SEC16A AHSG KIF14 MACF1 SMARCE1 C3 OXSM NUP93 GCN1 PLS3 GNL3 HSP90AB1 | 1.10e-07 | 1422 | 188 | 35 | int:SOX2 |
| Interaction | SIRT7 interactions | MYH10 IRS4 NUMA1 KRI1 LARP1 RFC1 KRR1 LCP1 IQGAP1 ITPR3 DDX10 GTF2I UTP15 BAZ2A MCM3AP SEC16A KIF14 PYGB MACF1 NUP93 GCN1 NUP160 GNL3 KPNB1 | 1.24e-07 | 744 | 188 | 24 | int:SIRT7 |
| Interaction | BIRC3 interactions | MRPS31 IRS4 COX4I1 AZGP1 NUMA1 KRI1 LARP1 DBN1 RFC1 RRBP1 KRR1 OGDH IQGAP1 NOMO1 DDX10 LIG3 TRMT10C GTF2I UTP15 SUPT16H SMARCE1 SCPEP1 NUP93 CHST2 GCN1 PLS3 NUP160 UBE2Q2 GNL3 MYBPC1 KPNB1 HSP90AB1 | 7.43e-07 | 1334 | 188 | 32 | int:BIRC3 |
| Interaction | ECT2 interactions | MYH10 MYO5B ABCA13 NUMA1 KRI1 LARP1 DBN1 KLHL20 IQGAP1 NOMO1 ESYT2 MISP GTF2I UTP15 SUPT16H SEC16A AHSG KIF14 COBL MACF1 NUP93 DNAH9 PLS3 KPNB1 HSP90AB1 | 8.24e-07 | 887 | 188 | 25 | int:ECT2 |
| Interaction | RHBDD1 interactions | IRS4 COX4I1 LARP1 RRBP1 LCP1 TF JMJD1C ORM1 ESYT2 A2ML1 TMX4 SEC16A AHSG MACF1 C3 | 9.37e-07 | 346 | 188 | 15 | int:RHBDD1 |
| Interaction | C9orf78 interactions | IRS4 NUMA1 OCRL RFC1 IQGAP1 ESYT2 TRMT10C GTF2I CEP120 NOMO2 PRKAA1 TMX4 INTS4 PYGB ELP2 NUP93 NUP160 FBXW11 KPNB1 HSP90AB1 | 1.50e-06 | 620 | 188 | 20 | int:C9orf78 |
| Interaction | GLDC interactions | MYH10 IRS4 COX4I1 RBM10 KRI1 LARP1 DBN1 RRBP1 DDX10 GTF2I SEC16A COBL KPNB1 HSP90AB1 | 2.04e-06 | 321 | 188 | 14 | int:GLDC |
| Interaction | GNG8 interactions | 2.66e-06 | 125 | 188 | 9 | int:GNG8 | |
| Interaction | AURKAIP1 interactions | MRPS31 MYH10 KRI1 RFC1 RRBP1 KRR1 OGDH DDX10 TRMT10C SEC16A NUP93 MMAB GNL3 | 2.81e-06 | 284 | 188 | 13 | int:AURKAIP1 |
| Interaction | CAPZA2 interactions | MYH10 MYO5B DUSP8 NUMA1 DBN1 LCP1 OGDH IQGAP1 ITPR3 MISP WASHC5 SEC16A KIF14 COBL MACF1 PLS3 | 2.96e-06 | 430 | 188 | 16 | int:CAPZA2 |
| Interaction | TSSK2 interactions | 3.76e-06 | 26 | 188 | 5 | int:TSSK2 | |
| Interaction | KIF23 interactions | ZWILCH MYH10 MYO5B ABCA13 KRI1 LARP1 DBN1 RFC1 KRR1 IQGAP1 ITPR3 LIG3 MISP TRMT10C UTP15 SUPT16H AHSG KIF14 MACF1 NUP93 DMD GCN1 TOP3B GNL3 KPNB1 HSP90AB1 | 3.80e-06 | 1031 | 188 | 26 | int:KIF23 |
| Interaction | NAA40 interactions | ZHX3 STRN3 MYH10 IRS4 MAP1A RBM10 NUMA1 LARP1 OCRL DBN1 RFC1 RRBP1 DDX10 LIG3 GTF2I BAZ2A SUPT16H SEC16A MACF1 SMARCE1 IRS2 GCN1 GNL3 KPNB1 HSP90AB1 | 4.70e-06 | 978 | 188 | 25 | int:NAA40 |
| Interaction | NUP43 interactions | SZT2 KRI1 LARP1 RFC1 JMJD1C LIG3 GTF2I BAZ2A MCM3AP SUPT16H SMARCE1 NUP93 RAPGEF2 MGA DNAH9 NUP160 GNL3 KPNB1 HSP90AB1 | 6.55e-06 | 625 | 188 | 19 | int:NUP43 |
| Interaction | PDHA1 interactions | MRPS31 IRS4 COX4I1 NUMA1 DBN1 RRBP1 OGDH TRMT10C GTF2I POLR3E MTIF2 SUPT16H SEC16A KIF14 OXSM NUP93 ANKRD34C MMAB TOP3B GNL3 KPNB1 | 7.41e-06 | 750 | 188 | 21 | int:PDHA1 |
| Interaction | LRRC31 interactions | MYH10 NUMA1 LARP1 RRBP1 IQGAP1 ITPR3 SUPT16H SEC16A GCN1 TOP3B | 2.36e-05 | 205 | 188 | 10 | int:LRRC31 |
| Interaction | DYSF interactions | 2.42e-05 | 62 | 188 | 6 | int:DYSF | |
| Interaction | CIT interactions | ANKRD35 MYH10 RBM10 NUMA1 KRI1 LARP1 RNF213 DBN1 IQGAP1 ITPR3 DDX10 LIG3 MISP TRMT10C GTF2I UTP15 MROH2B SUPT16H INTS4 KIF14 MACF1 NUP93 SPAG17 GCN1 TOP3B PLS3 NUP160 GNL3 KPNB1 HSP90AB1 | 3.13e-05 | 1450 | 188 | 30 | int:CIT |
| Interaction | GDPD1 interactions | 3.38e-05 | 40 | 188 | 5 | int:GDPD1 | |
| Interaction | OBSL1 interactions | MRPS31 RBM10 NUMA1 RFC1 KRR1 IQGAP1 ITPR3 DDX10 MISP SLC9C1 KCNA4 SUPT16H KIF14 MACF1 NUP93 ZC3H7B MGA GCN1 NUP160 GNL3 KPNB1 HSP90AB1 | 3.74e-05 | 902 | 188 | 22 | int:OBSL1 |
| Interaction | KCTD13 interactions | PITPNM2 SLC12A6 STRN3 MYH6 MYH10 MAP1A MYO5B COX4I1 LARP1 SORBS1 DBN1 RRBP1 OGDH TF CADM2 IQGAP1 MISP HSPA12A WASHC5 PRKAA1 SEC16A PYGB MACF1 DMD RAPGEF2 PLS3 LGI1 KPNB1 HSP90AB1 | 3.91e-05 | 1394 | 188 | 29 | int:KCTD13 |
| Interaction | IFI16 interactions | RBM10 NUMA1 KRI1 LARP1 RNF213 RFC1 KRR1 DDX10 LIG3 UTP15 BAZ2A MCM3AP SUPT16H KIF14 NUP93 PLS3 NUP160 GNL3 FBXW11 | 4.13e-05 | 714 | 188 | 19 | int:IFI16 |
| Interaction | JAK3 interactions | 4.20e-05 | 136 | 188 | 8 | int:JAK3 | |
| Interaction | AGRN interactions | MYH8 IRS4 SNX14 SUPT16H KIF14 C3 ADAM17 DMD TOP3B MYBPC1 HSP90AB1 | 4.39e-05 | 267 | 188 | 11 | int:AGRN |
| Interaction | CFTR interactions | CFAP47 MYH2 MYH6 MYH8 MYH10 IRS4 AZGP1 DBN1 RRBP1 LCP1 TF RYR3 IQGAP1 SORCS1 ESYT2 MISP GTF2I PRKAA1 SUPT16H SEC16A AHSG PYGB MACF1 C3 ADAM17 DMD GCN1 PLS3 KPNB1 HSP90AB1 | 4.57e-05 | 1480 | 188 | 30 | int:CFTR |
| Interaction | HECTD1 interactions | MYH10 NUMA1 KRI1 LARP1 RFC1 RRBP1 KRR1 OGDH GMNN IQGAP1 DDX10 LIG3 ACAD11 UTP15 SUPT16H MACF1 NUP93 ZC3H7B GCN1 TOP3B GNL3 FBXW11 HSP90AB1 | 4.74e-05 | 984 | 188 | 23 | int:HECTD1 |
| Interaction | TLX2 interactions | 5.72e-05 | 142 | 188 | 8 | int:TLX2 | |
| Interaction | SMC5 interactions | ZHX3 IRS4 COX4I1 RBM10 NUMA1 KRI1 LARP1 DBN1 RFC1 RRBP1 KRR1 JMJD1C DDX10 LIG3 GTF2I BAZ2A SUPT16H SEC16A SMARCE1 MGA GNL3 KPNB1 HSP90AB1 | 6.06e-05 | 1000 | 188 | 23 | int:SMC5 |
| Interaction | NSD2 interactions | RBM10 AZGP1 NUMA1 APOA1 KRR1 TF IQGAP1 ORM1 GTF2I BAZ2A TOP3B | 6.32e-05 | 278 | 188 | 11 | int:NSD2 |
| Interaction | KCNA3 interactions | IRS4 SZT2 ABCA13 NUMA1 LARP1 RNF213 OCRL RRBP1 JMJD1C IQGAP1 ESYT2 KCNA4 ARHGAP12 SEC16A COBL MACF1 IRS2 GCN1 PLS3 KPNB1 HSP90AB1 | 6.69e-05 | 871 | 188 | 21 | int:KCNA3 |
| Interaction | PRKX interactions | 6.73e-05 | 46 | 188 | 5 | int:PRKX | |
| Interaction | FNDC1 interactions | 6.73e-05 | 24 | 188 | 4 | int:FNDC1 | |
| Interaction | DOCK5 interactions | 8.25e-05 | 111 | 188 | 7 | int:DOCK5 | |
| Interaction | YAP1 interactions | MYH10 IRS4 RBM10 NUMA1 LARP1 DBN1 RRBP1 OGDH JMJD1C IQGAP1 GTF2I BAZ2A SUPT16H SEC16A KIF14 SMARCE1 RAPGEF2 MGA GCN1 KRT25 PLS3 FBXW11 KPNB1 HSP90AB1 | 8.79e-05 | 1095 | 188 | 24 | int:YAP1 |
| Interaction | COBL interactions | 8.95e-05 | 78 | 188 | 6 | int:COBL | |
| Interaction | ACTC1 interactions | DPF1 ZHX3 MYH10 IRS4 NUMA1 SORBS1 DBN1 LCP1 DDX10 GTF2I WASHC5 KIF14 COBL SMARCE1 DMD KAT14 PLS3 KPNB1 | 9.19e-05 | 694 | 188 | 18 | int:ACTC1 |
| Interaction | MAPRE1 interactions | NUMA1 LARP1 DBN1 RRBP1 DNAJC2 MISP SEC16A KIF14 COBL MACF1 SMARCE1 NUP93 NUP160 KPNB1 HSP90AB1 | 1.01e-04 | 514 | 188 | 15 | int:MAPRE1 |
| Interaction | ACE2 interactions | MYH10 IRS4 RBM10 AZGP1 NUMA1 KRI1 LARP1 OCRL DBN1 DNAJC2 LIG3 TRMT10C GTF2I PTPRD SUPT16H AHSG ADAM17 NUP93 MMAB GCN1 NUP160 GNL3 KPNB1 HSP90AB1 | 1.02e-04 | 1106 | 188 | 24 | int:ACE2 |
| Interaction | H3C1 interactions | MYH10 NUMA1 KRI1 LARP1 RFC1 RRBP1 KRR1 JMJD1C DNTTIP1 DDX10 LIG3 XIRP2 BAZ2A SUPT16H AHSG MORC3 MGA DNAH9 TOP3B KAT14 GNL3 | 1.08e-04 | 901 | 188 | 21 | int:H3C1 |
| Interaction | NUP85 interactions | 1.11e-04 | 156 | 188 | 8 | int:NUP85 | |
| Interaction | PRC1 interactions | ANKRD35 MYH10 COX4I1 RBM10 NUMA1 LARP1 DBN1 KRR1 IQGAP1 LIG3 MISP UTP15 SUPT16H KIF14 COBL SNAPC4 GCN1 NUP160 GNL3 MYBPC1 KPNB1 HSP90AB1 | 1.13e-04 | 973 | 188 | 22 | int:PRC1 |
| Interaction | ACTG1 interactions | CYBB MAP1A DBN1 LCP1 MKS1 IQGAP1 ARHGAP12 PYGB COBL SMARCE1 TOP3B KAT14 PLS3 UBE2Q2 HSP90AB1 | 1.14e-04 | 520 | 188 | 15 | int:ACTG1 |
| Interaction | EGFL8 interactions | 1.22e-04 | 52 | 188 | 5 | int:EGFL8 | |
| Interaction | BICD1 interactions | KIAA0232 KRI1 SORBS1 OCRL LCP1 CEP120 N4BP2 ARHGAP12 KIF14 C3 | 1.25e-04 | 250 | 188 | 10 | int:BICD1 |
| Interaction | CAP1 interactions | 1.46e-04 | 207 | 188 | 9 | int:CAP1 | |
| Interaction | FGD5 interactions | 1.46e-04 | 207 | 188 | 9 | int:FGD5 | |
| Interaction | AR interactions | DPF1 ZHX3 MYH10 MYO5B RBM10 NUMA1 LARP1 RNF213 JMJD1C HMG20B DNTTIP1 LIG3 GTF2I SUPT16H SEC16A INTS4 SMARCE1 MORC3 MGA GCN1 GNL3 HSP90AB1 | 1.49e-04 | 992 | 188 | 22 | int:AR |
| Interaction | USP36 interactions | IRS4 KIAA0232 KRI1 RFC1 RRBP1 KRR1 LCP1 TF DDX10 GTF2I UTP15 SUPT16H KIF14 C3 GNL3 KPNB1 | 1.64e-04 | 599 | 188 | 16 | int:USP36 |
| Interaction | ZFP36L2 interactions | 1.69e-04 | 211 | 188 | 9 | int:ZFP36L2 | |
| Interaction | TXNIP interactions | 1.75e-04 | 212 | 188 | 9 | int:TXNIP | |
| Interaction | STX17 interactions | 2.00e-04 | 265 | 188 | 10 | int:STX17 | |
| Interaction | PLEC interactions | MAP1A RRBP1 KRR1 IQGAP1 NOMO1 N4BP2 MCM3AP MTR KIF14 MACF1 RAPGEF2 TOP3B PLS3 | 2.09e-04 | 430 | 188 | 13 | int:PLEC |
| Interaction | PINK1 interactions | MYH10 IRS4 NUMA1 LARP1 DBN1 TF IQGAP1 ORM1 MISP A2ML1 SUPT16H C3 NUP93 GCN1 CTSV PLS3 HSP90AB1 | 2.20e-04 | 679 | 188 | 17 | int:PINK1 |
| Interaction | EYA1 interactions | 2.23e-04 | 59 | 188 | 5 | int:EYA1 | |
| Interaction | ITLN2 interactions | 2.23e-04 | 59 | 188 | 5 | int:ITLN2 | |
| Interaction | P2RX6 interactions | 2.23e-04 | 59 | 188 | 5 | int:P2RX6 | |
| Interaction | TEFM interactions | 2.38e-04 | 221 | 188 | 9 | int:TEFM | |
| Interaction | LGI1 interactions | 2.41e-04 | 60 | 188 | 5 | int:LGI1 | |
| Interaction | MEN1 interactions | ZHX3 MYH10 RBM10 NUMA1 KRI1 LARP1 RNF213 RFC1 KRR1 JMJD1C IQGAP1 DDX10 LIG3 MISP GTF2I BAZ2A WASHC5 MCM3AP SUPT16H COBL SMARCE1 NUP93 | 2.50e-04 | 1029 | 188 | 22 | int:MEN1 |
| Interaction | MYH6 interactions | 2.51e-04 | 94 | 188 | 6 | int:MYH6 | |
| Interaction | CHMP4C interactions | MYH10 KRI1 LARP1 RNF213 DBN1 IQGAP1 ITPR3 MISP GTF2I SUPT16H SEC16A MACF1 NUP93 NUP160 GNL3 KPNB1 HSP90AB1 | 2.52e-04 | 687 | 188 | 17 | int:CHMP4C |
| Interaction | HNRNPCL2 interactions | 2.62e-04 | 274 | 188 | 10 | int:HNRNPCL2 | |
| Interaction | SCN2B interactions | 2.66e-04 | 95 | 188 | 6 | int:SCN2B | |
| Interaction | SYNE3 interactions | SORBS1 OCRL NOMO1 ITPR3 ESYT2 N4BP2 TMX4 SEC16A KIF14 MACF1 TTC13 TOP3B KPNB1 | 2.85e-04 | 444 | 188 | 13 | int:SYNE3 |
| Interaction | DNAJC28 interactions | 2.98e-04 | 97 | 188 | 6 | int:DNAJC28 | |
| Interaction | PHLPP1 interactions | IRS4 RBM10 KRI1 LARP1 RRBP1 JMJD1C MISP GTF2I SEC16A AHSG GCN1 | 3.06e-04 | 333 | 188 | 11 | int:PHLPP1 |
| Interaction | SNRK interactions | 3.06e-04 | 35 | 188 | 4 | int:SNRK | |
| Interaction | G3BP1 interactions | MYH10 IRS4 COX4I1 KRI1 LARP1 SORBS1 DBN1 TRMT10C CSNK1G2 PRKAA1 KIF14 MACF1 NUP93 ZC3H7B GCN1 TOP3B NUP160 GNL3 KPNB1 | 3.14e-04 | 835 | 188 | 19 | int:G3BP1 |
| Interaction | IL17RD interactions | 3.35e-04 | 15 | 188 | 3 | int:IL17RD | |
| Interaction | H2BC8 interactions | ZHX3 NUMA1 RFC1 DNTTIP1 DDX10 LIG3 GTF2I BAZ2A SUPT16H SEC16A SMARCE1 MORC3 FTO MGA KDM4B | 3.44e-04 | 576 | 188 | 15 | int:H2BC8 |
| Interaction | CDCA5 interactions | 3.48e-04 | 140 | 188 | 7 | int:CDCA5 | |
| Interaction | RDX interactions | 3.48e-04 | 284 | 188 | 10 | int:RDX | |
| Interaction | SUZ12 interactions | NUMA1 LARP1 DBN1 KRR1 KLHL20 LIG3 GTF2I UTP15 N4BP2 SUPT16H KIF14 NUP93 MORC3 GCN1 FBXW11 KPNB1 | 3.67e-04 | 644 | 188 | 16 | int:SUZ12 |
| Interaction | EED interactions | MYH10 MYO5B SZT2 NUMA1 DBN1 KRR1 IQGAP1 DDX10 LIG3 GTF2I XIRP2 BAZ2A WASHC5 PRKAA1 SUPT16H MACF1 ADAM17 NUP93 MORC3 FTO MGA PLS3 NUP160 GNL3 FBXW11 KPNB1 HSP90AB1 | 4.23e-04 | 1445 | 188 | 27 | int:EED |
| Interaction | ST6GALNAC6 interactions | 4.33e-04 | 104 | 188 | 6 | int:ST6GALNAC6 | |
| Interaction | PRKAG2 interactions | 4.34e-04 | 68 | 188 | 5 | int:PRKAG2 | |
| GeneFamily | Myosin heavy chains | 3.08e-06 | 15 | 128 | 4 | 1098 | |
| GeneFamily | Keratins, type I | 9.98e-04 | 28 | 128 | 3 | 608 | |
| GeneFamily | Zinc fingers CW-type | 1.02e-03 | 7 | 128 | 2 | 96 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.35e-03 | 8 | 128 | 2 | 658 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.73e-03 | 9 | 128 | 2 | 1234 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.88e-06 | 197 | 190 | 10 | M5210 | |
| Coexpression | LEE_BMP2_TARGETS_DN | ZWILCH ENC1 LARP1 HMGCR DCLRE1B KRR1 GMNN DNAJC2 NOMO1 TRMT10C UTP15 NOMO2 RPS6KA6 NUP93 MCTP2 FIGNL1 NUP160 GNL3 NOMO3 RAD17 KPNB1 | 3.81e-06 | 922 | 190 | 21 | MM1068 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | PHYKPL RBM10 ENC1 KRI1 DBN1 RFC1 GMNN KLHL20 DDX10 LIG3 SMARCE1 ELP2 OXSM ADAM17 FTO MGA FIGNL1 FBXW11 KPNB1 | 4.08e-06 | 776 | 190 | 19 | M1107 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | PHYKPL RBM10 ENC1 KRI1 DBN1 RFC1 GMNN KLHL20 DDX10 LIG3 SMARCE1 ELP2 OXSM ADAM17 FTO MGA FIGNL1 FBXW11 KPNB1 | 5.66e-06 | 794 | 190 | 19 | MM982 |
| Coexpression | AIZARANI_LIVER_C17_HEPATOCYTES_3 | 9.73e-06 | 102 | 190 | 7 | M39119 | |
| Coexpression | GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP | 1.39e-05 | 196 | 190 | 9 | M8157 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP | 1.45e-05 | 197 | 190 | 9 | M8159 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_DC_DN | 1.45e-05 | 197 | 190 | 9 | M5196 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 STRN3 GALNT1 ENC1 KLHL20 DNAJC2 DDX10 MTIF2 ARHGAP12 MTR KIF14 MACF1 ADAM17 DMD RAPGEF2 FTO NUP160 VPS13B FBXW11 | 1.62e-05 | 856 | 190 | 19 | M4500 |
| Coexpression | LEE_BMP2_TARGETS_DN | ZWILCH ENC1 LARP1 HMGCR DCLRE1B KRR1 GMNN DNAJC2 NOMO1 TRMT10C UTP15 RPS6KA6 NUP93 MCTP2 FIGNL1 NUP160 GNL3 RAD17 KPNB1 | 3.42e-05 | 904 | 190 | 19 | M2325 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-09 | 184 | 191 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-09 | 184 | 191 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-09 | 184 | 191 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-08 | 176 | 191 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.17e-07 | 200 | 191 | 9 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.17e-07 | 200 | 191 | 9 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-07 | 158 | 191 | 8 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.91e-07 | 161 | 191 | 8 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-07 | 164 | 191 | 8 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.35e-06 | 184 | 191 | 8 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 1.78e-06 | 191 | 191 | 8 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 1.78e-06 | 191 | 191 | 8 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 2.33e-06 | 198 | 191 | 8 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.33e-06 | 198 | 191 | 8 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 2.51e-06 | 200 | 191 | 8 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.51e-06 | 200 | 191 | 8 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 200 | 191 | 8 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 200 | 191 | 8 | df90b67490cd649de3e3a713762ffbc34a698899 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.51e-06 | 200 | 191 | 8 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 200 | 191 | 8 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 145 | 191 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 158 | 191 | 7 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.76e-06 | 159 | 191 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal-Igfbp4_(Entorhinal_cortex)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.91e-06 | 60 | 191 | 5 | 604f050cafb1c2378a6957831833d47ff555c1fd | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal-Igfbp4_(Entorhinal_cortex)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.91e-06 | 60 | 191 | 5 | 831efcadd99ad04d37cd763ecf8aaa439b09046d | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.25e-06 | 161 | 191 | 7 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-06 | 161 | 191 | 7 | 274838cebdc7af1db32d309dfe42ef7ccd3c190b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-05 | 173 | 191 | 7 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 182 | 191 | 7 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.55e-05 | 185 | 191 | 7 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.71e-05 | 188 | 191 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-05 | 126 | 191 | 6 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.77e-05 | 189 | 191 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.77e-05 | 189 | 191 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.96e-05 | 192 | 191 | 7 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 192 | 191 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.02e-05 | 77 | 191 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.03e-05 | 193 | 191 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.10e-05 | 194 | 191 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.17e-05 | 195 | 191 | 7 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.24e-05 | 196 | 191 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-05 | 196 | 191 | 7 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.24e-05 | 196 | 191 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 197 | 191 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.31e-05 | 197 | 191 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.39e-05 | 198 | 191 | 7 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 2.39e-05 | 198 | 191 | 7 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.47e-05 | 199 | 191 | 7 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-05 | 199 | 191 | 7 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 199 | 191 | 7 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 199 | 191 | 7 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.47e-05 | 199 | 191 | 7 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 199 | 191 | 7 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-05 | 199 | 191 | 7 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 199 | 191 | 7 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.47e-05 | 199 | 191 | 7 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.55e-05 | 200 | 191 | 7 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-05 | 200 | 191 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 200 | 191 | 7 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 200 | 191 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.55e-05 | 200 | 191 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-05 | 200 | 191 | 7 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | droplet-Liver-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 146 | 191 | 6 | d9df42f8e44018b149a84f07c540cdba74d6374a | |
| ToppCell | droplet-Liver-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 146 | 191 | 6 | a9fa64617c7fb7a66de77360c5642c1da91e465c | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 150 | 191 | 6 | ee2da4f684add821f2653d5db8eef46cd95c0fda | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 152 | 191 | 6 | acfafdb64bd5b0eb7371b04cfef51ed2798e9b30 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 152 | 191 | 6 | 9d6c88ceca0569dbeb12e488acec7fcb7f972f03 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 5.80e-05 | 156 | 191 | 6 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 157 | 191 | 6 | b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.01e-05 | 157 | 191 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 158 | 191 | 6 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 6.44e-05 | 159 | 191 | 6 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-05 | 160 | 191 | 6 | 8de1fc75241d9bf2b355afa0e9ef39fea1977177 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.15e-05 | 162 | 191 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 163 | 191 | 6 | a794540f2d8984f963c08f05175e4bc916fcc224 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 163 | 191 | 6 | 03d9fa615d9d02ef98e20f28a10aaa6894dd4960 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 163 | 191 | 6 | 1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 163 | 191 | 6 | 7e82c1b7849eca895732df2da74ac6430bd9ba7a | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 164 | 191 | 6 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 164 | 191 | 6 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 166 | 191 | 6 | 5c132f505dc5f699c87913f140344fc9f8e7e0f5 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.18e-05 | 166 | 191 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-05 | 167 | 191 | 6 | 881f64db8dea3faa7588bf04d87c20924a4e5952 | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.73e-05 | 168 | 191 | 6 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.73e-05 | 168 | 191 | 6 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 168 | 191 | 6 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 171 | 191 | 6 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 171 | 191 | 6 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | droplet-Liver|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 172 | 191 | 6 | cd0e8f48836a16026b47ade06abadf26b53f581f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 173 | 191 | 6 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.03e-04 | 173 | 191 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-04 | 173 | 191 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 173 | 191 | 6 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 1.06e-04 | 174 | 191 | 6 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 174 | 191 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 174 | 191 | 6 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 175 | 191 | 6 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-04 | 175 | 191 | 6 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 175 | 191 | 6 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-04 | 175 | 191 | 6 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| Drug | SM-2 | 2.81e-09 | 87 | 189 | 10 | CID000486033 | |
| Drug | fast white | 1.24e-06 | 42 | 189 | 6 | CID000024008 | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | STRN3 MYH10 ENC1 NUMA1 KLHL20 IQGAP1 BTBD7 SNAPC4 RAPGEF2 ZC3H7B | 5.38e-06 | 194 | 189 | 10 | 4312_DN |
| Drug | 2-iodopropane | 5.56e-06 | 5 | 189 | 3 | CID000006362 | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | NUMA1 HMGCR OCRL SIX1 LCP1 KLHL20 HMG20B ITPR3 ADAM17 HSP90AB1 | 5.89e-06 | 196 | 189 | 10 | 6591_UP |
| Drug | B0683 | 6.13e-06 | 117 | 189 | 8 | CID006398969 | |
| Drug | purealin | 8.55e-06 | 58 | 189 | 6 | CID006419303 | |
| Drug | AC1LADJ6 | 1.33e-05 | 130 | 189 | 8 | CID000486032 | |
| Drug | pyridoxine | 1.45e-05 | 95 | 189 | 7 | CID000001054 | |
| Drug | corrinoid | 2.20e-05 | 41 | 189 | 5 | CID006438343 | |
| Drug | AG-012559 [369370-06-9]; Down 200; 10uM; PC3; HT_HG-U133A | LARP1 LCP1 KLHL20 HMG20B ITPR3 ATP2C2 ADAM17 ZC3H7B HSP90AB1 | 3.00e-05 | 189 | 189 | 9 | 6920_DN |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 3.00e-05 | 189 | 189 | 9 | 6649_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.26e-05 | 191 | 189 | 9 | 4303_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 3.26e-05 | 191 | 189 | 9 | 4283_DN | |
| Drug | creatine | 3.53e-05 | 193 | 189 | 9 | CID000000586 | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 3.83e-05 | 195 | 189 | 9 | 1688_DN | |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | 3.99e-05 | 196 | 189 | 9 | 7310_UP | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 4.15e-05 | 197 | 189 | 9 | 2514_DN | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A | 4.15e-05 | 197 | 189 | 9 | 1311_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A | 4.66e-05 | 200 | 189 | 9 | 1592_DN | |
| Drug | 4-chloroaniline | 5.04e-05 | 202 | 189 | 9 | CID000007812 | |
| Drug | NSC107658 | TPO MYH2 MYH6 MYH8 MYH10 MYO5B HPSE2 LCP1 KLHL20 POLR3E PLS3 | 5.32e-05 | 306 | 189 | 11 | CID000002919 |
| Drug | formycin triphosphate | 6.44e-05 | 51 | 189 | 5 | CID000122274 | |
| Drug | oxovanadium | 6.56e-05 | 120 | 189 | 7 | CID000024411 | |
| Drug | 1,3-dimethyl-benzimidazole-2-thione | 6.85e-05 | 2 | 189 | 2 | CID000123191 | |
| Drug | butyl formate | 6.85e-05 | 2 | 189 | 2 | CID000011614 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.93e-06 | 15 | 185 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | sugar consumption measurement | 1.11e-05 | 120 | 185 | 7 | EFO_0010158 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.18e-05 | 121 | 185 | 7 | EFO_0004612, EFO_0005271 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.20e-05 | 222 | 185 | 9 | EFO_0008317, EFO_0020943 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.15e-05 | 239 | 185 | 9 | EFO_0008317, EFO_0020945 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 5.12e-05 | 12 | 185 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 5.12e-05 | 12 | 185 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 6.62e-05 | 13 | 185 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | migraine disorder | INPP5B RNF213 HPSE2 SORBS1 NMUR2 RRBP1 CADM2 PTPRD MACF1 DMD | 9.23e-05 | 357 | 185 | 10 | MONDO_0005277 |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.07e-04 | 171 | 185 | 7 | DOID:9352 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | INPP5B KIAA0232 ENC1 LARP1 RFC1 LCP1 TF GMNN IQGAP1 GTF2I KCNA4 COG1 CSNK1G2 IRS2 CHST2 FTO ZC3H7B MMAB GNL3 KPNB1 HSP90AB1 | 1.18e-04 | 1347 | 185 | 21 | EFO_0005192 |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.51e-04 | 80 | 185 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | Drug toxicity | 1.90e-04 | 84 | 185 | 5 | C0013221 | |
| Disease | Adverse reaction to drug | 1.90e-04 | 84 | 185 | 5 | C0041755 | |
| Disease | Infantile Obesity | 2.33e-04 | 4 | 185 | 2 | C4553478 | |
| Disease | Cerebellar Hemiataxia | 2.33e-04 | 4 | 185 | 2 | C0750994 | |
| Disease | Cerebellar Dysmetria | 2.33e-04 | 4 | 185 | 2 | C0234162 | |
| Disease | Hypermetria (finding) | 2.33e-04 | 4 | 185 | 2 | C3668822 | |
| Disease | renal fibrosis (is_marker_for) | 2.33e-04 | 4 | 185 | 2 | DOID:0050855 (is_marker_for) | |
| Disease | Childhood Overweight | 2.33e-04 | 4 | 185 | 2 | C4521075 | |
| Disease | Adiadochokinesis | 2.33e-04 | 4 | 185 | 2 | C0234357 | |
| Disease | Pediatric Obesity | 2.33e-04 | 4 | 185 | 2 | C2362324 | |
| Disease | Adolescent Overweight | 2.33e-04 | 4 | 185 | 2 | C4704956 | |
| Disease | Infant Overweight | 2.33e-04 | 4 | 185 | 2 | C4704955 | |
| Disease | Adolescent Obesity | 2.33e-04 | 4 | 185 | 2 | C4317171 | |
| Disease | myopathy (implicated_via_orthology) | 2.35e-04 | 48 | 185 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | mean platelet volume | PITPNM2 SLC12A6 STRN3 KIAA0232 NUMA1 SORBS1 LCP1 JMJD1C DNTTIP1 ESYT2 BAZ2A INTS4 IRS2 TTC13 CHST2 MMAB PLS3 | 2.51e-04 | 1020 | 185 | 17 | EFO_0004584 |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.54e-04 | 49 | 185 | 4 | EFO_0022256 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.76e-04 | 91 | 185 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.76e-04 | 264 | 185 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 2.97e-04 | 51 | 185 | 4 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | Cerebellar Ataxia | 3.86e-04 | 5 | 185 | 2 | C0007758 | |
| Disease | Restless Legs Syndrome | 3.86e-04 | 5 | 185 | 2 | C0035258 | |
| Disease | Joubert syndrome with ocular defect | 3.86e-04 | 5 | 185 | 2 | C4274118 | |
| Disease | Malignant neoplasm of breast | SORBS1 DBN1 TEK SORCS1 DDX10 PTPRD N4BP2 PRKAA1 MTR MACF1 OXSM DMD FTO DNAH9 PLS3 VPS13B PGBD3 | 4.53e-04 | 1074 | 185 | 17 | C0006142 |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 5.34e-04 | 105 | 185 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | total lipids in IDL | 5.55e-04 | 60 | 185 | 4 | EFO_0022161 | |
| Disease | Paratuberculosis | 5.77e-04 | 6 | 185 | 2 | C0030524 | |
| Disease | Idiopathic Membranous Glomerulonephritis | 5.77e-04 | 6 | 185 | 2 | C0086445 | |
| Disease | Heymann Nephritis | 5.77e-04 | 6 | 185 | 2 | C1704378 | |
| Disease | Membranous glomerulonephritis | 5.77e-04 | 6 | 185 | 2 | C0017665 | |
| Disease | calcium measurement | PITPNM2 ZWILCH MAP1A NUMA1 HPSE2 HMGCR TRMT10C AHSG KIF14 PYGB MACF1 IRS2 | 6.45e-04 | 628 | 185 | 12 | EFO_0004838 |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 7.51e-04 | 65 | 185 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | immature platelet fraction | 7.76e-04 | 114 | 185 | 5 | EFO_0009187 | |
| Disease | muscular atrophy (biomarker_via_orthology) | 7.86e-04 | 29 | 185 | 3 | DOID:767 (biomarker_via_orthology) | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 9.41e-04 | 69 | 185 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | apolipoprotein A 1 measurement | PITPNM2 MAP1A MYO5B APOA1 RRBP1 LCP1 TF JMJD1C UTP15 DEF6 MACF1 NUP93 MMAB MGA | 9.71e-04 | 848 | 185 | 14 | EFO_0004614 |
| Disease | docosahexaenoic acid measurement | 1.26e-03 | 127 | 185 | 5 | EFO_0007761 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.27e-03 | 189 | 185 | 6 | EFO_0009932 | |
| Disease | esterified cholesterol measurement | 1.30e-03 | 128 | 185 | 5 | EFO_0008589 | |
| Disease | Distal arthrogryposis | 1.37e-03 | 9 | 185 | 2 | cv:C0265213 | |
| Disease | amnestic disorder (implicated_via_orthology) | 1.37e-03 | 9 | 185 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | N6,N6-dimethyllysine measurement | 1.37e-03 | 9 | 185 | 2 | EFO_0800100 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 1.70e-03 | 10 | 185 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.76e-03 | 137 | 185 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | sleep apnea | 2.02e-03 | 40 | 185 | 3 | EFO_0003877 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.19e-03 | 144 | 185 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | obesity (implicated_via_orthology) | 2.43e-03 | 215 | 185 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 2.48e-03 | 12 | 185 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | gait measurement | 2.61e-03 | 150 | 185 | 5 | EFO_0007680 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.84e-03 | 45 | 185 | 3 | EFO_0022236 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.94e-03 | 94 | 185 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.04e-03 | 225 | 185 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | Myopia | 3.09e-03 | 385 | 185 | 8 | HP_0000545 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 3.17e-03 | 96 | 185 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | phospholipids:total lipids ratio | 3.18e-03 | 227 | 185 | 6 | EFO_0020946 | |
| Disease | free cholesterol in small VLDL measurement | 3.21e-03 | 47 | 185 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 3.21e-03 | 47 | 185 | 3 | EFO_0022275 | |
| Disease | triacylglycerol 46:2 measurement | 3.39e-03 | 14 | 185 | 2 | EFO_0010402 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 3.54e-03 | 99 | 185 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | Adenoid Cystic Carcinoma | 3.67e-03 | 100 | 185 | 4 | C0010606 | |
| Disease | Acute kidney injury | 3.81e-03 | 101 | 185 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 3.81e-03 | 101 | 185 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 3.81e-03 | 101 | 185 | 4 | C0022660 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.83e-03 | 50 | 185 | 3 | EFO_0022247 | |
| Disease | free cholesterol in large LDL measurement | 4.05e-03 | 51 | 185 | 3 | EFO_0022176 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 4.05e-03 | 51 | 185 | 3 | EFO_0022242 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 4.22e-03 | 104 | 185 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | mean corpuscular hemoglobin concentration | MRPS31 ZHX3 MYH2 LARP1 RFC1 LCP1 TF KCNA4 PRKAA1 SEC16A MACF1 IRS2 MMAB VPS13B HSP90AB1 | 4.26e-03 | 1105 | 185 | 15 | EFO_0004528 |
| Disease | total lipids in LDL measurement | 4.28e-03 | 52 | 185 | 3 | EFO_0022308 | |
| Disease | sexual dimorphism measurement | PITPNM2 INPP5B APOA1 HMGCR LCP1 JMJD1C CEP120 DEF6 SEC16A MACF1 NUP93 FTO MGA GCN1 FBXW11 | 4.29e-03 | 1106 | 185 | 15 | EFO_0021796 |
| Disease | vision disorder | 4.43e-03 | 16 | 185 | 2 | MONDO_0021084 | |
| Disease | nervousness | 4.43e-03 | 16 | 185 | 2 | NCIT_C74532 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 4.51e-03 | 53 | 185 | 3 | EFO_0022340 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 5.00e-03 | 17 | 185 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | phosphatidylcholine 40:6 measurement | 5.00e-03 | 17 | 185 | 2 | EFO_0010389 | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 5.00e-03 | 17 | 185 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 5.27e-03 | 56 | 185 | 3 | EFO_0022250 | |
| Disease | total lipids in large LDL | 5.53e-03 | 57 | 185 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 5.53e-03 | 57 | 185 | 3 | EFO_0021901 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 5.53e-03 | 57 | 185 | 3 | EFO_0022284 | |
| Disease | sphingosine 1-phosphate measurement | 5.60e-03 | 18 | 185 | 2 | EFO_0800185 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DWQKEPRKYENAIDQ | 511 | Q6UWY0 | |
| PRKYENAIDQWLKTH | 516 | Q6UWY0 | |
| KENLSPKWNEVYEAL | 431 | A0FGR8 | |
| LKEPASLKWLENDLY | 366 | P0C6C1 | |
| ELYKNLWGAVLQESK | 661 | O15254 | |
| SAVPKFDQNLDTKWY | 16 | O60911 | |
| NYCEKLLPWLDKSIE | 216 | Q13202 | |
| PKEKTYETDLAVLQW | 1506 | Q9UIF9 | |
| HKQFYKELAWVPEAQ | 241 | Q92782 | |
| FIFIDPKNIQDALKW | 1051 | A8K2U0 | |
| LEELKKQQADDLQWY | 291 | Q2M329 | |
| DKNRWEDPGKQLYNV | 1216 | P01024 | |
| VWDPQKVQYDLKSQF | 266 | Q86UQ4 | |
| NQEFWPCLLEKAYAK | 161 | Q6MZZ7 | |
| VQPYLDDFQKKWQEE | 121 | P02647 | |
| AQAWGQELKALLEKY | 846 | Q8N283 | |
| EWNDKKYSLDIGNLL | 321 | O60423 | |
| LLSYLEKANKWLNEV | 1271 | P11532 | |
| IKKQLFPDLYSKEWN | 396 | Q9H816 | |
| LKTLDPKDWKNQDHY | 76 | Q99543 | |
| ADNSEPVWKKYLDQF | 96 | O75185 | |
| SPYKFRNLDGQKEWV | 151 | Q8IUZ5 | |
| LYGSEEQKKQWLEPL | 481 | Q709F0 | |
| NIKTDPVDIYKSWVN | 1086 | P46940 | |
| VADKTEDYLWLKLNQ | 406 | Q8N1F7 | |
| SLKLEIWDTAGQEKY | 66 | Q9H0T7 | |
| YSDPKPKINEDWLCN | 206 | P98175 | |
| LFWDKETQISPEKFQ | 306 | O95072 | |
| PTLWVKLYKSENLDN | 1071 | P69849 | |
| SENEPWVDKYKPETQ | 86 | O75943 | |
| NLELLKEPDKAFYDW | 181 | A0A1B0GVH7 | |
| EKLWNVAAPLYLKQS | 676 | Q96HW7 | |
| PTANQWDYKNIIEKL | 1581 | Q14573 | |
| EANADLEQKIKGWYE | 106 | Q7Z3Y9 | |
| KWRVLPSSTNYQEKE | 491 | Q86VD1 | |
| DLNYVPLKAQEWKTE | 421 | Q9NWU1 | |
| QRKKEQWYAGINPSD | 631 | Q8IVT2 | |
| SPKDLELYENWNKTF | 656 | Q6PIW4 | |
| WAEKFEPEYSQIKQE | 691 | Q6PKG0 | |
| YIDQEELNKTKPIWT | 276 | P08238 | |
| LKPWETYNQNTKEEH | 1591 | Q15058 | |
| PTLWVKLYKSENLDN | 1071 | Q5JPE7 | |
| EKGNPYTKLEENAWN | 171 | Q3ZCV2 | |
| LEQKYWALGQKDEAL | 1551 | P78559 | |
| SKVIYKNLNPVWDEI | 231 | Q6DN12 | |
| IEVKLYNLLPEKSWE | 181 | P17735 | |
| YNLLPEKSWEIDLKQ | 186 | P17735 | |
| KEWNYSPKETNRKES | 946 | Q8IV33 | |
| SWIYQQKLEDPFQKH | 11 | Q9GZQ4 | |
| KSLKEWNYPLFQDLN | 71 | Q9NPP4 | |
| CYEEKQIQAKTSWDP | 711 | P46199 | |
| KPDYWSDKLQKEAEA | 2406 | Q8IWI9 | |
| QEKYTSEKPVLWQAQ | 286 | Q8IYA8 | |
| LTPKDDEFYQQWQLK | 31 | Q9C0B1 | |
| NYCTDKKPAAINWIE | 686 | P04035 | |
| QKVELNKEDPTYTVW | 61 | Q6ZT52 | |
| HDPIRDQSWYVNKKL | 2421 | Q15652 | |
| NDLKKYDVPLSWEQA | 1781 | O60318 | |
| PWQGLKADTLKERYQ | 251 | P78368 | |
| VEAKLPWFKQAQELE | 501 | Q8N6G6 | |
| YNITGWLDKNKDPLN | 591 | P13535 | |
| IFQLYEKIKVPVDWN | 426 | P13796 | |
| KYPALTKPENQDIDW | 376 | P13797 | |
| EVAAQKPSEDIYKNW | 56 | C9JC47 | |
| KPWDVAQDKENTFIL | 916 | Q92628 | |
| YDPDVNAKQIWIDKT | 41 | Q14149 | |
| YNITGWLEKNKDPLN | 591 | Q9UKX2 | |
| ELKRLNPQWDGEKLY | 396 | P22079 | |
| NPQWDGEKLYQEARK | 401 | P22079 | |
| KILDLYKHPDNIDVW | 621 | P07202 | |
| ADGKEQYERLKLTWQ | 111 | Q9H8E8 | |
| YDGKIKVWDLQAALD | 461 | Q9UKB1 | |
| PTLWVKLYKSENLDN | 1071 | Q15155 | |
| GYQPEWILKQKEISD | 251 | Q9NX36 | |
| EVAAQKPSEDIYKNW | 56 | P0CG43 | |
| QPERYELWKQGKDLT | 326 | O94953 | |
| EEANADLEQKIKGWY | 106 | Q7Z3Y8 | |
| EEANADLEQKIKGWY | 101 | Q7Z3Z0 | |
| VDWLYKVEPQLAEDQ | 2801 | O94854 | |
| AQEEADYIEWLKGQK | 196 | Q8N9T8 | |
| DYIEWLKGQKEIRNP | 201 | Q8N9T8 | |
| YLKECWPLVQKALNE | 71 | Q13601 | |
| WYLKEQKAVAAPVEL | 56 | Q8NA19 | |
| KLWKENPGLVEQYLS | 171 | Q92616 | |
| ANIDWDKLYKREVQP | 331 | Q9UK32 | |
| KDSQAALPKYVLINW | 71 | Q16643 | |
| DPNEAKQWLYLEKFK | 126 | O43301 | |
| PLSENWIEEYKKQVF | 171 | Q9BZ72 | |
| WKSATNLPQLKELYQ | 816 | P49916 | |
| KKYNISWELGNEPNN | 251 | Q8WWQ2 | |
| WQVKPDENSKAFYVP | 51 | Q8IWW6 | |
| QKSSDPYVFWNELEK | 166 | Q96QZ0 | |
| TAAYREVWQVNLKPK | 191 | Q9Y4H2 | |
| LLKEVQKYPNAELAW | 941 | Q02218 | |
| KGNQLWEYDPVKLTL | 501 | Q10472 | |
| CLNIVERYDPKENKW | 426 | Q9Y2M5 | |
| PISQEYLKDTLQKWI | 341 | Q8WTW3 | |
| ENDVKNWTPELQKYL | 491 | Q9Y6W3 | |
| TAQETKQAPKWYQLL | 101 | Q8N960 | |
| YKHTLNQIDEVKVWP | 56 | P02765 | |
| KSLNELGIKELYAWD | 211 | O75128 | |
| WSNPAQQTLYFDDKK | 56 | Q8N3J6 | |
| LDEIQKYTQQKVSPW | 796 | Q5VV63 | |
| DFLYKLSPKEWLEEQ | 261 | Q494V2 | |
| LQASEQDILKYLIKW | 456 | Q9P203 | |
| QELIQDVLKQGYLWK | 211 | Q9H4E7 | |
| TSKDPDIKAQYQQRW | 66 | Q14974 | |
| DEKNWGLSVYADKPE | 136 | P02763 | |
| KQKTLYGRPNWDNEF | 506 | P04839 | |
| INKPDEESYCKQWLN | 706 | P32019 | |
| ENLESWLNYLKKELP | 186 | Q9BVP2 | |
| EQIDHYKESQDKLPW | 91 | Q5JUW0 | |
| YKESQDKLPWQAAFI | 96 | Q5JUW0 | |
| LKQVEHYDPTINKWT | 411 | O14682 | |
| LSLKNPEYVWVHEKA | 266 | Q13206 | |
| TVFKQLEELPEKWNN | 1186 | Q9NYC9 | |
| LYTWKKTDQVPEIND | 751 | Q6IA86 | |
| LQLDKPASGVKEEWY | 446 | P78347 | |
| NPIQGLASKWDYEKN | 151 | P13073 | |
| NLWSNYLPKGEIIEK | 446 | Q9UHW9 | |
| QSYEFLQKKHAEEPW | 191 | Q9NVU0 | |
| GKYWPIDNFDELDIK | 2851 | Q6ZTR5 | |
| IYNPATQADWTAKKL | 21 | P35580 | |
| YEALPKKLQQADWAP | 146 | O95954 | |
| KAGPILELEQWIDKY | 146 | Q96EY8 | |
| KSPRDWEQFEYKIQA | 111 | Q14980 | |
| PSDTTKYLLEQLEKW | 666 | P23468 | |
| QNAWQLHKTYDEKPV | 496 | Q8N328 | |
| LDKEVSYNWDPKDAA | 841 | O14654 | |
| KENPSSQYWKEVAEK | 91 | O75496 | |
| AEWSKLQPTEKQRYL | 106 | Q9P0W2 | |
| SSEEIPKYWDQGLVK | 376 | Q8N807 | |
| NPYLSVKQKVEHIEW | 361 | Q92665 | |
| DKKLQLLTYNWAPDL | 2656 | Q5T011 | |
| ADDYTVKLWDIPNSK | 141 | Q8TED0 | |
| WDVDQGLISKLKEQY | 341 | Q13033 | |
| YSRKVWDQVKASNPD | 76 | Q969G3 | |
| LLNWVYNTRKEKEGP | 581 | Q4G0N8 | |
| LKLLQWDYQKKELPE | 306 | Q8N4U5 | |
| VENLLWVDKYKPTSL | 581 | P35251 | |
| QLKWKALYSDPKSLE | 396 | Q9HB40 | |
| WNKDPEATEKLLRYA | 636 | Q99707 | |
| EDFVPNTEKILNYWK | 71 | A0A096LP01 | |
| SVADPWKKIQLLYSQ | 31 | Q86V20 | |
| PKLQQLWLKAHYVEA | 81 | Q15475 | |
| LGQVPWLLNQYKDKE | 231 | Q7Z745 | |
| TVDYNILGWLEKNKD | 586 | P13533 | |
| PIKEWLNSCDLKYTE | 881 | Q9Y5B9 | |
| LPNWLINSYKKVDAA | 1321 | Q12769 | |
| LLVPEQKDSSSWYQK | 121 | Q01968 | |
| ELKTFWKYLEPVLNN | 291 | Q6Q759 | |
| DERPKWDNKAQYLLS | 16 | Q96N87 | |
| KPTEKNLYADIEAAW | 136 | Q5VST6 | |
| RAIKQLDYEWKVVNP | 426 | Q13131 | |
| AKSYPNEEKDAWDVK | 301 | P78536 | |
| LNLLDYKWHKEPLQQ | 71 | Q9Y4C5 | |
| WLFENQPIDKIKESQ | 1066 | A4UGR9 | |
| WEKLPNKYEKLFQDL | 826 | Q9Y4G8 | |
| SNNVPFSWKIKDYLE | 3706 | Q63HN8 | |
| KPETYWVLQAKVNTD | 236 | O95985 | |
| EEWALLDPSQKKLYR | 16 | Q8TBZ8 | |
| LQNYILEKKWQSVEP | 131 | Q9H1E5 | |
| LYDWHVKLQKVDPDS | 236 | Q8WVN8 | |
| PYDKILESENWKKLV | 186 | A0A1B0GVZ9 | |
| KDHWAKNLPFLIEDY | 461 | Q8NBP0 | |
| DNKWVVQKYIETPLL | 386 | A6PVC2 | |
| NLYQSEKPQKWRVEI | 521 | Q9H900 | |
| VDAWEPYKAAKTALN | 301 | Q12768 | |
| EEWALLDPAQKNLYK | 26 | Q13360 | |
| PDPWAKNLNEKDYEL | 566 | P02787 | |
| NYTEWLQDLKEKGPT | 1081 | Q9P2E9 | |
| EKQELWKYTIDNVSP | 256 | Q9NXB0 | |
| AYLPDDKNKSIVWDE | 2121 | O15027 | |
| YQPWLDLKISSKVDA | 121 | Q9Y5W7 | |
| KYAADPQDKHWLAEQ | 241 | Q9H147 | |
| DDPAVKWQLNLYKDV | 3421 | Q15413 | |
| KVSDWKLEILQNGLY | 81 | Q9UNG2 | |
| SPEEIDLKNEPWYKF | 556 | Q9BX66 | |
| AQVDQLYRNPKEWTK | 786 | P11216 | |
| YNADDKQSVWEKPSV | 111 | Q6NWY9 | |
| ELLLSQCPWKEYKSD | 131 | Q6NWY9 | |
| YPVLDWNDIKFQDVI | 816 | Q02763 | |
| WQVEKVNPIKLYEEN | 296 | Q9HCJ6 | |
| KWKDQNIEDQYKNPR | 46 | Q08AG5 | |
| EWQLLDPSQKNLYKD | 21 | P51523 | |
| AQITKQKWEAEPVYV | 161 | P25311 | |
| IWPYNKKDSDRNEQL | 2946 | Q7Z7G8 | |
| KGYWAPEEDAKLLQA | 401 | Q5SXM2 | |
| PKQEDWILAYSQDQK | 281 | Q8WY21 | |
| TKYPEEQLKIWFTAQ | 341 | Q9H4I2 | |
| LPLDKYLQWEIGNKN | 336 | Q7L0Y3 | |
| DSLYDWNVKLLKVDQ | 281 | Q7Z7E8 | |
| WRNGQVVEPDKDLKY | 701 | Q9UGR2 | |
| ENEFKKQIWLLFEYP | 286 | P22459 | |
| KPNDIETFKIENNWY | 331 | O95970 | |
| VPKGTDQNWAQKLYD | 516 | Q9ULV0 | |
| QTEPQDFALLWKIEK | 1016 | Q86UW6 | |
| ANKDYIIISWKQPAV | 521 | P52179 | |
| WELLKNAKPSEYEKI | 211 | Q00872 |